HPV疫苗免费接种！守护女性健康的国家承诺

Core Points - The inclusion of the HPV vaccine in the national immunization program is a significant step towards reducing the burden of cervical cancer in China and promoting public health [1][5][6] - Girls born after November 10, 2011, who are 13 years old or older will be eligible for free vaccination with the bivalent HPV vaccine, receiving two doses spaced six months apart [3][6] - The initiative aims to improve vaccination rates and ensure equitable access across different regions and income groups, thereby enhancing overall health protection for the population [6][7] Group 1 - The HPV vaccine serves as the first line of defense against cervical cancer, which poses a serious threat to women's health, with approximately 151,000 new cases and 56,000 deaths reported in 2022 [5] - The decision to target 13-year-old girls for free vaccination is based on considerations of protection effectiveness, cost-effectiveness, and operational feasibility [6] - The domestic production capacity for the bivalent HPV vaccine is 55 million doses annually, sufficient to meet market demand, with vaccines certified by the World Health Organization [7] Group 2 - The inclusion of the HPV vaccine in the national immunization program marks a new phase in China's immunization efforts, reflecting a commitment to women's health and global health equity [7] - Collaborative efforts among various departments will ensure the smooth implementation of the vaccination policy, aiming to create a comprehensive health protection network [7]